Procurement of an assay to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in human blood samples for the UK Biobank study of seroprevalence of COVID-19
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the upper-middle of the Health & Social Care band — a substantial contract for the sector. Based on 32,734 valued Health & Social Care tenders in our corpus.
UK Biobank is conducting a study of seroprevalence of COVID-19 in the population of up to 20,000 of its participants and their adult children and grandchildren (the "Study").
The Study (which is funded by the Department of Health and Social Care) aims to collect blood samples from study participants each month for an initial period of six months and measure these samples to assess the extent of previous infection with the SARS-CoV-2 coronavirus (by measuring blood antibodies) in different locations and age groups across the UK.
In order to enable the Study, UK Biobank needed a supplier to provide an assay which could be used to measure blood antibodies.
There was an urgent need to identify a supplier of an assay to enable UK Biobank to design the study - in particular the method of blood collection - to enable the study to start without delay.
The study needed to start as soon as possible to enable UK Biobank to report the assay results to DHSC to assist the DHSC in its monitoring of COVID-19 in the population as part of its urgent public health response to the COVID-19 pandemic.
Whilst it is UK Biobank that has entered into the contract directly with the assay supplier, the DHSC will be remunerating the supplier direct (rather than payment being made through UK Biobank)
What the supplier must deliver
In order to enable the Study, UK
In order to enable the Study, UK Biobank needed a supplier to provide an assay which could be used to measure blood antibodies.
There was an urgent need to identify
There was an urgent need to identify a supplier of an assay to enable UK Biobank to design the study.
The study needed to start as soon
The study needed to start as soon as possible to enable UK Biobank to report the assay results to DHSC to assist the DHSC in its monitoring of COVID-19 in the population as part of its urgent public health response to the COVID-19 pandemic.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at UK Biobank Ltd, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- 48549b7d-8cc7-4667-895e-ff95fc1502c3
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- MT219946
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Health & Social Care
UK Biobank Ltd’s tender network
Assembling the network…